Tubocapsenolide A targets C-terminal cysteine residues of HSP90 to exert the anti-tumor effect

Zhu, DR; Li, S; Chen, C; Wang, SB; Zhu, JM; Kong, LY; Luo, JG

Kong, LY; Luo, JG (corresponding author), China Pharmaceut Univ, Sch Tradit Chinese Pharm, Jiangsu Key Lab Bioact Nat Prod Res, Nanjing 210009, Peoples R China.

PHARMACOLOGICAL RESEARCH, 2021; 166 ():

Abstract

Heat shock protein 90 (HSP90) is a chaperone protein that has been shown to regulate cancer progression. As a result, HSP90 has emerged as an attracti......

Full Text Link